Sinco Pharmaceuticals Holdings

Sinco Pharmaceuticals Holdings Limited, established in 2011 and headquartered in Chengdu, China, is an investment holding company specializing in the marketing, promotion, and channel management of imported pharmaceutical products and medical devices. Its portfolio includes human albumin solutions, antibiotics, and other pharmaceuticals, such as Octapharma, Axetine, Medocef, Esafosfina, Taurolite, and Tamifil. Additionally, Sinco engages in the purchase and sale of pharmaceutical products and provides warehouse facilities for these products. The company operates through three business segments: biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. Sinco is a subsidiary of Risun Investments Limited.